ENDRA Life Sciences P/E Ratio

ENDRA Life Sciences (NDRA) currently reports a P/E ratio of -0.75. That is below the Technology sector average of 14.35. Use the charts on this page to explore ENDRA Life Sciences's P/E ratio history and peer comparisons.

ENDRA Life Sciences's P/E ratio of -0.75 is lower than the Technology sector average of 14.35. That is roughly 105.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates ENDRA Life Sciences's market price to a fundamental measure such as earnings, sales, or book value. At -0.75, NDRA can look expensive or cheap only in context — versus its own history, growth rate, and Technology peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -0.75, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 14.35. From there, open related valuation or income-statement pages for ENDRA Life Sciences, and consider following NDRA for alerts when major investors trade the stock.

ENDRA Life Sciences is classified in the Technology sector. On P/E ratio, it currently shows -0.75 versus a sector average near 14.35. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NDRA with unrelated industries.